Depression is associated with increased mortality 10 years after coronary artery bypass surgery

Ingrid Connerney1, Richard P Sloan, Peter A Shapiro

  • 1Division of Quality and Safety, University of Maryland Medical Center, Baltimore, Maryland 21201, USA. iconnerney@umm.edu

Psychosomatic Medicine
|September 16, 2010
PubMed

Insights

Major depressive disorder (MDD) independently predicts cardiac mortality up to 10 years after coronary artery bypass graft (CABG) surgery. Elevated depressive symptoms, measured by the Beck Depression Inventory (BDI), also indicated increased cardiac death risk in CABG patients.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Coronary artery bypass graft (CABG) surgery is a common procedure for cardiovascular disease.
  • The long-term impact of depression on mortality after CABG surgery is not well understood.
  • Previous research has focused on depression's link to mortality after myocardial infarction.

Purpose of the Study:

  • To investigate the independent association between depression and cardiac mortality 10 years post-CABG.
  • To examine the relationship between depression and all-cause mortality after CABG surgery.
  • To identify predictors of long-term mortality in patients following CABG.

Main Methods:

  • A prospective study involving 309 patients hospitalized after CABG surgery.
  • Depression assessment using the Diagnostic Interview Schedule and Beck Depression Inventory (BDI) before discharge.
  • Mortality data collected via the National Center for Health Statistics and phone interviews for up to 11.5 years.

Main Results:

  • 20% of patients met criteria for major depressive disorder (MDD); 28% had elevated depressive symptoms (BDI ≥10).
  • MDD was an independent predictor of cardiac mortality (HR, 1.8; p = .04), along with age and left ventricular ejection fraction.
  • While age, ejection fraction, and diabetes predicted all-cause mortality, MDD did not.

Conclusions:

  • Depression, identified through structured interviews and BDI scores, is significantly linked to increased cardiac mortality 10 years after CABG.
  • These findings highlight the importance of addressing depression in post-CABG patient care.
  • Depression assessment and management may improve long-term cardiac outcomes in CABG survivors.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...